Ident. | Authors (with country if any) | Title |
---|
000407 (2019) |
Matthias Friedrich [Royaume-Uni] ; Mathilde Pohin [Royaume-Uni] ; Fiona Powrie [Royaume-Uni] | Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. |
000424 (2019) |
Davide Giuseppe Ribaldone [Italie] ; Rinaldo Pellicano [Italie] ; Marta Vernero [Italie] ; Gian Paolo Caviglia [Italie] ; Giorgio Maria Saracco [Italie] ; Mario Morino [Italie] ; Marco Astegiano [Italie] | Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis. |
000454 (2019) |
Kyle Driscoll [États-Unis] ; Aparna Deshpande [États-Unis] ; Andrew Chapp [États-Unis] ; Kefeng Li [États-Unis] ; Rupali Datta [États-Unis] ; Wusirika Ramakrishna [Inde] | Anti-inflammatory and immune-modulating effects of rice callus suspension culture (RCSC) and bioactive fractions in an in vitro inflammatory bowel disease model. |
000509 (2019) |
Renata F. Amorim [Brésil] ; Eduardo R C. Viegas [Brésil] ; Antonio José V. Carneiro [Brésil] ; Barbara C. Esberard [Brésil] ; Evelyn S. Chinem [Brésil] ; Raquel S. Correa [Brésil] ; Luciana Rodrigues [Brésil] ; Marcelo Ribeiro-Alves [Brésil] ; Kelly S. Silva [Brésil] ; Heitor S. De Souza [Brésil] ; Ana Teresa P. Carvalho [Brésil] | Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil. |
000681 (2018) |
Webber Chan [Australie, Singapour] ; Hang Hock Shim [Singapour] ; Siew Chien Ng [République populaire de Chine] ; Jeffrey Liu [Australie] ; Christian Inglis [Australie] ; Kay Greveson [Royaume-Uni] ; Brandon Baraty [Australie] ; Craig Haifer [Australie] ; Rupert W L. Leong [Australie] | A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas. |
000760 (2018) |
Mohammad Al Mijan [Corée du Sud] ; Beong Ou Lim [Corée du Sud] | Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends. |
000767 (2018) |
Thi Le Phuong Nguyen [Hongrie] ; Ferenc Fenyvesi [Hongrie] ; Judit Remenyik [Hongrie] ; Judit Rita Homoki [Hongrie] ; Péter Gogolák [Hongrie] ; Ildik Bácskay [Hongrie] ; Pálma Fehér [Hongrie] ; Zoltán Ujhelyi [Hongrie] ; Gábor Vasvári [Hongrie] ; Mikl S Vecsernyés [Hongrie] ; Judit Váradi [Hongrie] | Protective Effect of Pure Sour Cherry Anthocyanin Extract on Cytokine-Induced Inflammatory Caco-2 Monolayers. |
000814 (2018) |
Rebecca Matro [États-Unis] ; Christopher F. Martin [États-Unis] ; Douglas Wolf [Géorgie (pays)] ; Samir A. Shah [États-Unis] ; Uma Mahadevan [États-Unis] | Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development. |
000973 (2018) |
Ross Dobie [Royaume-Uni] ; Vicky E. Macrae [Royaume-Uni] ; Chloe Pass [Royaume-Uni] ; Elspeth M. Milne [Royaume-Uni] ; S Faisal Ahmed [Royaume-Uni] ; Colin Farquharson [Royaume-Uni] | Suppressor of cytokine signaling 2 (Socs2) deletion protects bone health of mice with DSS-induced inflammatory bowel disease. |
000A33 (2018) |
Maximilian Hoffmann [Allemagne] ; Ulla Schwertassek [Allemagne] ; Aleksandra Seydel [Allemagne] ; Klaus Weber [Suisse] ; Werner Falk [Allemagne] ; Sunna Hauschildt [Allemagne] ; Jörg Lehmann [Allemagne] | A refined and translationally relevant model of chronic DSS colitis in BALB/c mice. |
000A54 (2018) |
Lluís Puig [Espagne] | Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others. |
000A71 (2017) |
Marie Str M Zangenberg [Danemark] ; Nir Horesh [Israël] ; Uri Kopylov [Israël] ; Alaa El-Hussuna [Danemark] | Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review. |
000A93 (2018) |
Valeria Dipasquale [Italie] ; Claudio Romano [Italie] | Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease. |
000B28 (2018) |
Marianna Lucaf [Italie] ; Biljana Stankovic [Serbie] ; Nikola Kotur [Serbie] ; Alessia Di Silvestre [Italie] ; Stefano Martelossi [Italie] ; Alessandro Ventura [Italie] ; Branka Zukic [Serbie] ; Sonja Pavlovic [Serbie] ; Giuliana Decorti [Italie] | Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease. |
000C04 (2017) |
Marjorie Argollo [Brésil] ; Gionata Fiorino [Italie] ; Pieter Hindryckx [Belgique] ; Laurent Peyrin-Biroulet [France] ; Silvio Danese [Italie] | Novel therapeutic targets for inflammatory bowel disease. |
000C81 (2017) |
M J Westerouen Van Meeteren [Pays-Bas] ; B. Hayee [Royaume-Uni] ; A. Inderson [Pays-Bas] ; A E Van Der Meulen [Pays-Bas] ; R. Altwegg [France] ; B. Van Hoek [Pays-Bas] ; G P Pageaux [France] ; T. Stijnen [Pays-Bas] ; D. Stein [États-Unis] ; P W J. Maljaars [Pays-Bas] | Safety of Anti-TNF Treatment in Liver Transplant Recipients: A Systematic Review and Meta-analysis. |
000D93 (2017) |
Juan José Sebastián Domingo [Espagne] | Review of the role of probiotics in gastrointestinal diseases in adults. |
000E99 (2016) |
Santiago García-L Pez [Espagne] | Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention. |
000F89 (2017) |
Lucas Wauters [Belgique] ; Thomas Billiet ; Konstantinos Papamichael ; Vera Ballet ; Steven Joniau ; Patrick Verschueren ; Geert Silversmit ; Gert Van Assche ; Séverine Vermeire ; Marc Ferrante | Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment. |
001094 (2016) |
Ryan A. Mcconnell [États-Unis] ; Uma Mahadevan [États-Unis] | Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications. |
001155 (2016) |
Min-Yu Chung [Corée du Sud] ; Jin-Taek Hwang [Corée du Sud] ; Jin Hee Kim [Corée du Sud] ; Dong-Hwa Shon [Corée du Sud] ; Hyun-Ku Kim [Corée du Sud] | Sarcodon aspratus Extract Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mouse Colon and Mesenteric Lymph Nodes. |